Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Transpl Int. 2017 Nov 2;31(2):198–211. doi: 10.1111/tri.13079

Table 4.

Heterogeneity across unadjusted and both adjusted models.*

Immunosuppression
Regimen
(Reference: IL2rAb)		 Proportion of
variance in
hierarchical model
explained by
center
characteristics
(Unadjusted)		 MOR
(Unadjusted)		 Proportion of
variance in
hierarchical
model
explained by
center, adjusted
for
donor/recipient
factors		 MOR
(Adjusted)		 Proportion of
variance in model
explained by
donor/recipient
characteristics
Thymoglobulin 0.55 6.76 0.58 7.64 0.11
Alemtuzumab 0.69 13.06 0.66 11.19 0.33
Other 0.58 7.69 0.61 8.60 0.10
No induction 0.56 7.00 0.58 7.66 0.12
*

Proportion of variance in hierarchical model is equal to the ICC.

ICC, intraclass correlation coefficient; IL2rAb, interleukin-2 receptor blocking antibodies; MOR, median odds ratio.